Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01952574
Brief Title: A Phase 2 Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

First Submitted : August 30, 2013
First Submitted that Met QC Criteria : September 27, 2013
First Posted : September 30, 2013 (Estimate)

Results First Submitted : June 11, 2018
Results First Submitted that Met QC Criteria : June 11, 2018
Results First Posted : July 10, 2018

Certification/Extension First Submitted : April 30, 2015
Certification/Extension First Submitted that Met QC Criteria : April 30, 2015
Certification/Extension First Posted : May 19, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : October 18, 2018
Last Update Posted : November 15, 2018